SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-20-091459
Filing Date
2020-08-06
Accepted
2020-08-06 16:21:04
Documents
63
Period of Report
2020-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q tm2020550d3_10q.htm 10-Q 529511
2 EXHIBIT 10.1 tm2020550d3_ex10-1.htm EX-10.1 8467
3 EXHIBIT 31.1 tm2020550d3_ex31-1.htm EX-31.1 10508
4 EXHIBIT 31.2 tm2020550d3_ex31-2.htm EX-31.2 10464
5 EXHIBIT 32.1 tm2020550d3_ex32-1.htm EX-32.1 4948
6 GRAPHIC tm2020550d3_ex10-1img001.jpg GRAPHIC 16967
  Complete submission text file 0001104659-20-091459.txt   4879690

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT cldx-20200630.xml EX-101.INS 1421718
8 XBRL TAXONOMY EXTENSION SCHEMA cldx-20200630.xsd EX-101.SCH 29151
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE cldx-20200630_cal.xml EX-101.CAL 45350
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE cldx-20200630_def.xml EX-101.DEF 109652
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE cldx-20200630_lab.xml EX-101.LAB 332802
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cldx-20200630_pre.xml EX-101.PRE 242492
Mailing Address 53 FRONTAGE ROAD SUITE 220 HAMPTON NJ 08827
Business Address 53 FRONTAGE ROAD SUITE 220 HAMPTON NJ 08827 908-200-7500
Celldex Therapeutics, Inc. (Filer) CIK: 0000744218 (see all company filings)

IRS No.: 133191702 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-15006 | Film No.: 201082014
SIC: 2835 In Vitro & In Vivo Diagnostic Substances